Cargando…

The impact of dehydroepiandrosterone in poor ovarian responders on assisted reproduction technology treatment

One in six couples worldwide will experience at least one infertility problem during their reproductive years. Between 5.6% and 35.1% of women will exhibit poor ovarian response. A variety of methods have been applied to improve ovarian response, including dehydroepiandrosterone. In the ovaries, deh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monteiro, Cecilia de Souza, Scheffer, Bruno Brum, de Carvalho, Rafaela Friche, Scheffer, Juliano Brum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Brazilian Society of Assisted Reproduction 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798587/ https://www.ncbi.nlm.nih.gov/pubmed/31251010 http://dx.doi.org/10.5935/1518-0557.20190045

Ejemplares similares

Age as A Predictor of Embryo Quality Regardless of The Quantitative Ovarian Response
por: Scheffer, Juliano Brum., et al.
Publicado: (2017)

A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol
por: Scheffer, Juliano Brum, et al.
Publicado: (2019)

Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF?
por: Scheffer, Juliano Augusto Brum, et al.
Publicado: (2018)

Which ovarian reserve marker relates to embryo quality on day 3 and blastocyst; age, AFC, AMH?
por: Scheffer, Juliano Brum, et al.
Publicado: (2021)

A comparison of the effects of three different estrogen used for endometrium preparation on the outcome of day 5 frozen embryo transfer cycle
por: Scheffer, Juliano Brum, et al.
Publicado: (2021)

Serum progesterone level in luteal phase improves pregnancy rate in fresh cycles with blastocyst embryo transfer
por: Scheffer, Juliano Brum, et al.
Publicado: (2023)

Anti-Mullerian as predictor of reproductive outcome in infertile women: follow up
por: Scheffer, Juliano B., et al.
Publicado: (2014)

Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study
por: Al-Turki, Haifa A.
Publicado: (2017)

Dehydroepiandrosterone Ameliorates Abnormal Mitochondrial Dynamics and Mitophagy of Cumulus Cells in Poor Ovarian Responders
por: Li, Chia-Jung, et al.
Publicado: (2018)

Dehydroepiandrosterone supplementation and the impact of follicular fluid metabolome and cytokinome profiles in poor ovarian responders
por: Viardot-Foucault, Veronique, et al.
Publicado: (2023)

The Application of Dehydroepiandrosterone on Improving Mitochondrial Function and Reducing Apoptosis of Cumulus Cells in Poor Ovarian Responders
por: Lin, Li-Te, et al.
Publicado: (2017)

Corifollitropin Alfa for Controlled Ovarian Stimulation in Assisted Reproductive Technologies: State of the Art
por: Carvalho, Bruno Ramalho de
Publicado: (2023)

Effect of Dehydroepiandrosterone Administration in Patients with Poor Ovarian Response According to the Bologna Criteria
por: Xu, Bei, et al.
Publicado: (2014)

The combination of dehydroepiandrosterone, transdermal testosterone, and growth hormone as an adjuvant therapy in assisted reproductive technology cycles in patients aged below 40 years with diminished ovarian reserve
por: Haydardedeoğlu, Bülent, et al.
Publicado: (2015)

Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study
por: Chern, Chyi-Uei, et al.
Publicado: (2018)

Efficacy and Safety of Pergoveris in Assisted Reproductive Technology—ESPART: rationale and design of a randomised controlled trial in poor ovarian responders undergoing IVF/ICSI treatment
por: Humaidan, P, et al.
Publicado: (2015)

Dehydroepiandrosterone enhances decidualization in women of advanced reproductive age
por: Gibson, Douglas A., et al.
Publicado: (2018)

Efficacy of dehydroepiandrosterone priming in women with poor ovarian response undergoing IVF/ICSI: a meta-analysis
por: Zhang, Jie, et al.
Publicado: (2023)

Impact of dehydroepiandrosterone on clinical outcome in poor responders: A pilot study in women undergoing in vitro fertilization, using bologna criteria
por: Jirge, Padma Rekha, et al.
Publicado: (2014)

Ovarian stimulation modalities in poor responders
por: ÖZKAN, Zehra Sema
Publicado: (2019)

Treatment modalities for poor ovarian responders
por: Di Guardo, Federica, et al.
Publicado: (2023)

The effect of Myo-inositol on fertility rates in poor ovarian responder in women undergoing assisted reproductive technique: a randomized clinical trial
por: Mohammadi, Sahar, et al.
Publicado: (2021)

Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)
por: Gleicher, Norbert, et al.
Publicado: (2011)

Luteal phase ovarian stimulation for poor ovarian responders
por: Zhang, Wei, et al.
Publicado: (2018)

Importance of Melatonin in Assisted Reproductive Technology and Ovarian Aging
por: Tamura, Hiroshi, et al.
Publicado: (2020)

Desiccant-assisted cooling: fundamentals and applications
por: Nóbrega, Carlos, et al.
Publicado: (2014)

Predicting IVF outcome in poor ovarian responders
por: Lebovitz, Oshrit, et al.
Publicado: (2022)

Effect of bromocriptine on the severity of ovarian hyperstimulation syndrome and outcome in high responders undergoing assisted reproduction
por: Sherwal, Vinita, et al.
Publicado: (2010)

Dehydroepiandrosterone-Sulfate, Insulin Resistance and Ovarian Volume Estimation in Patients With Polycystic Ovarian Syndrome
por: Christodoulaki, Chrysi, et al.
Publicado: (2017)

Comparison of mild ovarian stimulation with conventional ovarian stimulation in poor responders
por: Yoo, Ji Hee, et al.
Publicado: (2011)

An extremely patient-friendly and efficient stimulation protocol for assisted reproductive technology in normal and high responders
por: Huang, Chen-Yu, et al.
Publicado: (2018)

Biological versus chronological ovarian age: implications for assisted reproductive technology
por: Alviggi, Carlo, et al.
Publicado: (2009)

Ventilation mode performance against airborne respiratory infections in small office spaces: limits and rational improvements for Covid-19
por: Barbosa, Bruno Perazzo Pedroso, et al.
Publicado: (2021)

Dehydroepiandrosterone (DHEA) Supplementation in Rheumatic Diseases: A Systematic Review
por: Skare, Thelma L., et al.
Publicado: (2023)

Different anti‐Műllerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART): Clues to better ART outcomes
por: Ishii, Rena, et al.
Publicado: (2019)

Applying assisted reproductive technology and reproductive management to reduce CO(2)-equivalent emission in dairy and beef cattle: a review
por: Baruselli, Pietro Sampaio, et al.
Publicado: (2023)

Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis
por: Narkwichean, Amarin, et al.
Publicado: (2013)

The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women
por: Hu, Qiaofei, et al.
Publicado: (2017)

Dehydroepiandrosterone, Cancer, and Aging
por: Schwartz, Arthur G
Publicado: (2022)

Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate in Alzheimer's Disease: A Systematic Review and Meta-Analysis
por: Pan, Xiongfeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r252ghu8bv662fjfquoqhdhun6